Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC.QCLS · Entity 7735 | Director · Chief Medical Officer | April 13, 2026 | April 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Q/C TECHNOLOGIES, INC.
Report date April 13, 2026 · Filed April 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.00 · Expires 2036-04-13 | Direct | 50,000 |
Reported balance
After 2026-04-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-13 · Grant · Acquired 50,000 · Balance 50,000 F1: The stock options are subject to expiration if the Reporting Person ceases to be employed by or provide services to the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options are subject to expiration if the Reporting Person ceases to be employed by or provide services to the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 13, 2026 Filed Apr 15, 2026 22:29 UTC | Q/C TECHNOLOGIES, INC. QCLS · Entity 7735 | GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001493152-26-016911 · ownership.xml · derivative · entry 1 Glass Mitchell · CIK 0002023649 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2036-04-13 F1 · derivative.expiration_date: The stock options are subject to expiration if the Reporting Person ceases to be employed by or provide services to the Issuer. Read SEC document |
| November 14, 2025 Filed Nov 17, 2025 22:30 UTC | Q/C TECHNOLOGIES, INC. QCLS · Entity 7735 | GrantCommon stock | 11,420 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-023937 · ownership.xml · nonDerivative · entry 1 Glass Mitchell · CIK 0002023649 · Director · Director, Chief Medical Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 F1 · price: Represents a grant of Restricted Stock Units ("RSUs"). The RSUs were granted to the Reporting Person on October 3, 2025, subject to stockholder approval of an amendment to the Issuer's Q/C Technologies, Inc. 2021 Equity Incentive Plan (the "Plan Amendment"), under which the RSUs were granted. The Issuer's stockholders approved the Plan Amendment on November 14, 2025. The RSUs vested immediately upon issuance. Read SEC document |
| October 03, 2025 Filed Oct 6, 2025 21:30 UTC | Q/C TECHNOLOGIES, INC. QCLS · Entity 7735 | GrantCommon stock | 1,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-017130 · ownership.xml · nonDerivative · entry 1 Glass Mitchell · CIK 0002023649 · Director · Director, Chief Medical Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,080 F1 · price: Represents a grant of Restricted Stock Units ("RSUs"). The RSUs vested immediately upon grant on October 3, 2025. Read SEC document |
| April 17, 2025 Filed Apr 18, 2025 20:30 UTC | Q/C TECHNOLOGIES, INC. TNFA · Entity 7735 | GrantEmployee Stock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001641172-25-005424 · ownership.xml · derivative · entry 1 Glass Mitchell · CIK 0002023649 · Director · President, CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2035-04-16 F1 · derivative.expiration_date: The stock options are subject to expiration if the employment of the Reporting Person is terminated. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.